Feb 15, 2001|
Cadbury Schweppes profits up 15%
Cadbury Schweppes, parent of Cadbury India has recorded a 15% jump in net profits for the year ended December '00 on revenues of Rs 311 bn. Remarkably, the company's operating margins improved sharply by 100 basis points to 18.4%.
|Operating Profit (EBDIT)
|Operating Profit Margin (%)
|Profit before Tax
|Profit after Tax/(Loss)
|Net profit margin (%)
|Diluted Earnings per share
|P/E (at current price)
The outstanding performance was led by its two leading brands Dr Pepper and Seven Up. Profits from beverages segment was up by 36% in Europe and 14% in the US. However, combined volumes of these two brands grew by a marginal 1%. Intense competitive pricing and marketing activity in December affected volume growth of the brands. Its advertisement to sales ratio rose by 130 basis points to 19.4% during the year. Beverages business contributes nearly 50% of its total revenues.
The company's operating profit was driven by its managing for value program which focuses on enhancing shareholder return through operating efficiencies.
Apart from the organic growth, Cadbury (S) has also strengthened its business through significant acquisitions. In the US, the company acquired brands in beverages segment such as Snapple, Mauna Lai and Slush Puppie. In Australia it included the Lion Nathan soft drinks operations and Spring Valley. In France the company acquired the largest confectionery brand Hollywood. It also purchased confectionery brands in China and Argentina.
The company is likely to face challenging conditions in the first quarter of the current year with a slow down in the US economy. To de-risk its business the company is expanding its brands in Europe and emerging markets which are less exposed to a downturn.
Currently Cadbury Schweppes trades at a P/E multiple of 15 times its December '00 earnings with a market cap to sales ratio of 2 times. In the domestic market Cadbury India is trading at a P/E of 33 times with a market cap to sales ratio of 3 times.
More Views on News
Jun 20, 2017
While GSK consumer reported muted revenue growth, volumes are seen to be recovering.
Jul 18, 2016
Will investing in Bajaj Corp yield high returns on account of a rural revival in sight?
May 4, 2016
Should you subscribe to Parag Milk Foods' initial public offering?
More Views on News
Aug 7, 2017
The data tells us quite a different story from the one the government is trying to project.
Aug 10, 2017
Don't miss these proxy bets on growing companies or in a few years you will be looking back with regret.
Aug 8, 2017
Bharat-22 is one of the most diverse ETFs offered so far by the Government. Know here if you should invest...
Aug 12, 2017
The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.
Aug 7, 2017
Raksha Bandhan signifies the brother-sister bond. Here are 7 thoughtful financial gifts for sisters...
Copyright © Equitymaster Agora Research Private Limited. All rights reserved.
Any act of copying, reproducing or distributing this newsletter whether wholly or in part, for any purpose without the permission of Equitymaster is strictly prohibited and shall be deemed to be copyright infringement. LEGAL DISCLAIMER:
Equitymaster Agora Research Private Limited (hereinafter referred as 'Equitymaster') is an independent equity research Company. Equitymaster is not an Investment Adviser. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and Equitymaster will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein. Information contained herein does not constitute investment advice or a personal recommendation or take into account the particular investment objectives, financial situations, or needs of individual subscribers. Before acting on any recommendation, subscribers should consider whether it is suitable for their particular circumstances and, if necessary, seek an independent professional advice. This is not directed for access or use by anyone in a country, especially, USA or Canada, where such use or access is unlawful or which may subject Equitymaster or its affiliates to any registration or licensing requirement. All content and information is provided on an 'As Is' basis by Equitymaster. Information herein is believed to be reliable but Equitymaster does not warrant its completeness or accuracy and expressly disclaims all warranties and conditions of any kind, whether express or implied. Equitymaster may hold shares in the company/ies discussed herein. As a condition to accessing Equitymaster content and website, you agree to our Terms and Conditions of Use, available here
. The performance data quoted represents past performance and does not guarantee future results.SEBI (Research Analysts) Regulations 2014, Registration No. INH000000537.
Equitymaster Agora Research Private Limited. 103, Regent Chambers, Above Status Restaurant, Nariman Point, Mumbai - 400 021. India.
Telephone: +91-22-61434055. Fax: +91-22-22028550. Email: email@example.com. Website: www.equitymaster.com. CIN:U74999MH2007PTC175407